Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Hiring of New Graduates by Wholesalers Remains at Low Level: PJ Survey
September 9, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
September 9, 2002
- AstraZeneca Hires Largest Number of New Graduates in 2002: PJ Survey
September 9, 2002
- NEW PRODUCTS
September 9, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 9, 2002
- BUSINESS NEWS IN BRIEF
September 9, 2002
- REGULATORY NEWS IN BRIEF
September 9, 2002
- Korosho Requests Tax Reform to Beef Up Industry
September 9, 2002
- Korosho's FY2003 Budget Request Totals \19,523.7 Bil., Up 4.58%
September 9, 2002
- Drug Industry Vision Finalized
September 9, 2002
- Telmisartan, Brinzolamide Recommended for Approval
September 9, 2002
- PAL Amendment Discussed: Jiho Seminar -2-
September 9, 2002
- PAL Amendment Discussed: Jiho Seminar
September 9, 2002
- JAPANESE LANGUAGE BOOKS
September 9, 2002
- WORLD NEWS IN BRIEF
September 9, 2002
- MEDICAL DEVICE NEWS IN BRIEF
September 9, 2002
- Website News
September 9, 2002
- DIAGNOSTIC NEWS IN BRIEF
September 9, 2002
- Iressa's Price Set by Cost Calculation Method
September 2, 2002
- Tempstaff Dispatches 130 CRAs to Over 10 Drug Companies
September 2, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…